ANUH PHARMA
Quarterly Results Analysis [Sep2024]
ANUH PHARMA Quarterly Results
Standalone | Sep2024 UnAudited |
Jun2024 UnAudited |
Mar2024 UnAudited |
Dec2023 UnAudited |
Sep2023 UnAudited |
Jun2023 UnAudited |
Mar2023 Audited |
Dec2022 UnAudited |
---|---|---|---|---|---|---|---|---|
Revenues | ₹166 Cr | ₹138 Cr | ₹164 Cr | ₹172 Cr | ₹150 Cr | ₹161 Cr | ₹157 Cr | ₹139 Cr |
Expenses | ₹149 Cr | ₹127 Cr | ₹145 Cr | ₹148 Cr | ₹132 Cr | ₹148 Cr | ₹143 Cr | ₹126 Cr |
Operating Income | ₹17 Cr | ₹11 Cr | ₹19 Cr | ₹24 Cr | ₹18 Cr | ₹14 Cr | ₹14 Cr | ₹12 Cr |
Other Income | ₹3 Cr | ₹4 Cr | ₹3 Cr | ₹4 Cr | ₹2 Cr | ₹3 Cr | ₹1 Cr | ₹2 Cr |
Interest | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr | ₹0 Cr |
Depreciation | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr | ₹2 Cr |
Profit Before Tax | ₹18 Cr | ₹12 Cr | ₹20 Cr | ₹25 Cr | ₹18 Cr | ₹15 Cr | ₹13 Cr | ₹12 Cr |
Profit After Tax | ₹15 Cr | ₹10 Cr | ₹15 Cr | ₹19 Cr | ₹14 Cr | ₹12 Cr | ₹10 Cr | ₹9 Cr |
EPS | ₹3.00 | ₹1.90 | ₹3.06 | ₹3.81 | ₹2.76 | ₹2.35 | ₹1.92 | ₹1.86 |
Industry Peers & Returns | 1W | 1M | 1Y |
ANUH PHARMA | -6.5% | 7.7% | 46.9% |
SUN PHARMACEUTICAL INDUSTRIES | 1% | 4.6% | 47.5% |
CIPLA | -1.1% | -0.3% | 20.7% |
DR REDDYS LABORATORIES | 2.2% | 12.1% | 21.6% |
ZYDUS LIFESCIENCES | -2.7% | 0.8% | 43.8% |
DIVIS LABORATORIES | 1% | -3.2% | 59.3% |
MANKIND PHARMA | 0.8% | 12.8% | 52.4% |
TORRENT PHARMACEUTICALS | -1.5% | 5.9% | 55% |
LUPIN | 0.9% | 7.2% | 72.7% |
ANUH PHARMA Quarterly Revenues
Revenues | |
---|---|
Q-o-Q | 20.34 % |
Y-o-Y | 10.98 % |
Quarters | Revenues | % Change | |
---|---|---|---|
Sep2024 | ₹166 Cr | 20.34 | |
Jun2024 | ₹138 Cr | -15.85 | |
Mar2024 | ₹164 Cr | -4.77 | |
Dec2023 | ₹172 Cr | 15.09 | |
Sep2023 | ₹150 Cr | -7.40 | |
Jun2023 | ₹161 Cr | 2.65 | |
Mar2023 | ₹157 Cr | 13.39 | |
Dec2022 | ₹139 Cr | - |
ANUH PHARMA Quarterly Operating Profit
Operating Profit | |
---|---|
Q-o-Q | 59.73 % |
Y-o-Y | -6.01 % |
Quarters | Operating Profit | % Change | |
---|---|---|---|
Sep2024 | ₹17 Cr | 59.73 | |
Jun2024 | ₹11 Cr | -45.03 | |
Mar2024 | ₹19 Cr | -19.87 | |
Dec2023 | ₹24 Cr | 33.59 | |
Sep2023 | ₹18 Cr | 28.52 | |
Jun2023 | ₹14 Cr | -1.81 | |
Mar2023 | ₹14 Cr | 14.51 | |
Dec2022 | ₹12 Cr | - |
Operating Margins | |
---|---|
Q-o-Q | 32.77 % |
Y-o-Y | -15.32 % |
Quarters | Operating Margin% | % Change | |
---|---|---|---|
Sep2024 | 10.17% | 32.77 | |
Jun2024 | 7.66% | -34.70 | |
Mar2024 | 11.73% | -15.85 | |
Dec2023 | 13.94% | 16.07 | |
Sep2023 | 12.01% | 38.84 | |
Jun2023 | 8.65% | -4.42 | |
Mar2023 | 9.05% | 1.00 | |
Dec2022 | 8.96% | - |
ANUH PHARMA Quarterly Profit After Tax
Profit After Tax(PAT) | |
---|---|
Q-o-Q | 58.21 % |
Y-o-Y | 8.73 % |
Quarters | Profit After Tax | % Change | |
---|---|---|---|
Sep2024 | ₹15 Cr | 58.21 | |
Jun2024 | ₹10 Cr | -38.09 | |
Mar2024 | ₹15 Cr | -19.64 | |
Dec2023 | ₹19 Cr | 38.14 | |
Sep2023 | ₹14 Cr | 17.72 | |
Jun2023 | ₹12 Cr | 22.12 | |
Mar2023 | ₹10 Cr | 3.40 | |
Dec2022 | ₹9 Cr | - |
PAT Margins | |
---|---|
Q-o-Q | 31.49 % |
Y-o-Y | -2.05 % |
Quarters | PAT Margin(%) | % Change | |
---|---|---|---|
Sep2024 | 9.06 % | 31.49 | |
Jun2024 | 6.89 % | -26.47 | |
Mar2024 | 9.37 % | -15.66 | |
Dec2023 | 11.11 % | 20.11 | |
Sep2023 | 9.25 % | 27.06 | |
Jun2023 | 7.28 % | 18.95 | |
Mar2023 | 6.12 % | -8.79 | |
Dec2022 | 6.71 % | - |
ANUH PHARMA Quarterly Earnings Per Share (EPS)
EPS | |
---|---|
Q-o-Q | 57.89 % |
Y-o-Y | 8.70 % |
Quarters | EPS | % Change | |
---|---|---|---|
Sep2024 | ₹3 | 57.89 | |
Jun2024 | ₹1.9 | -37.91 | |
Mar2024 | ₹3.06 | -19.69 | |
Dec2023 | ₹3.81 | 38.04 | |
Sep2023 | ₹2.76 | 17.45 | |
Jun2023 | ₹2.35 | 22.40 | |
Mar2023 | ₹1.92 | 3.23 | |
Dec2022 | ₹1.86 | - |
You may also like the below Video Courses
SUN PHARMACEUTICAL INDUSTRIES LTD vs CIPLA LTD vs DR REDDYS LABORATORIES LTD
ZYDUS LIFESCIENCES LTD vs DIVIS LABORATORIES LTD vs MANKIND PHARMA LTD